Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening
Source:
Key Points
Question What is the cost-effectiveness of integrating smoking cessation interventions with varying intensity into lung cancer screening programs in the US?
Findings In this economic evaluation of 2520 individuals enrolled in 4 randomized clinical trials, trial data were projected over a lifetime horizon using an established microsimulation model. All cessation interventions combined with lung cancer screening were cost-saving vs screening alone, and high-intensity pharmacotherapy and counseling were associated with the greatest health gains, with an incremental cost-effectiveness ratio of $991 per quality-adjusted life-year.
Meaning The findings of this study suggest that integrating evidence-based smoking cessation interventions into lung cancer screening programs may represent a highly cost-effective use of health care resources.
- ISSUP members can join Networks to comment – Sign in or become a member